WOONSOCKET, R.I. — CVS Health has a unique opportunity, says chief merchandising officer Musab Balbale, and it’s twofold. First, as an operator of more than 9,000 stores focused on health and wellness, it has the ability to connect with members of the community seeking vital information, products and services. The company’s acquisitions of Oak Street
Most retailers talk a lot about the customer-centric imperative; CVS Health is doing something about it. In recent years, the company has been on a journey to strengthen the connective tissue uniting the various aspects of the organization, in an effort to provide a seamless experience for patients and consumers — no matter which CVS
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. The Good to Great principles of author and consultant Jim Collins — a great friend of NACDS — stand the
Viewed from almost any perspective, December 13, 2023, was a significant day in the history of mass retailing in America. On that day, to informally recognize the 90th anniversary of the National Association of Chain Drug Stores, America’s mass retailing community gathered together a not-so-random sampling of the individuals who created, advanced and immortalized health
In the second of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. 2023 was a pivotal year for health policy, to say the least. The swift implementation of the IRA’s Medicare Drug Price Negotiation Program (DPNP) by the Centers for Medicare and Medicaid Services (CMS), the growing
In the second of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The year 2023 marked another significant milestone for consumer health care with the continued growth of self-care driving the demand for safe and beneficial over-the-counter medicines, dietary supplements and consumer medical devices. Americans are prioritizing
In the second of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. Health care policy issues will inevitably emerge as a topic of the national debate in the 2024 election season. Access and affordability remain part of the dialogue, and implementation of the Inflation Reduction Act —
In the second of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. Former Defense Secretary Donald Rumsfeld once observed that “there are known knowns. There are things we know we know. We also know there are known unknowns. That is to say we know there are some
In the second of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The past year was significant for the pharmaceutical industry, as we witnessed major milestones and celebrated advancements in innovation. We saw an official end to the COVID-19 pandemic public health emergency and unlocked the potential
BENTONVILLE, Ark. — In the realm of health and wellness, the endpoint is where Walmart begins. After first gaining a thorough understanding of patients, customers and their needs, the company has set out to construct a dynamic ecosystem that promises to transform the way in which Americans get and stay well. In light of the
Leading chain drug and distribution executives provide their outlook for the coming year on the following pages, spelling out the challenges and opportunities that lie ahead for their companies and the industry. Prem Shah Executive Vice President, Chief Pharmacy Officer and President, Pharmacy and Consumer Wellness, CVS Health The need for accessible and affordable care
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. Specialty pharmacy continues to be dynamic, demanding and disruptive. As the market continues to demand specialization in drug distribution and
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. 2023 was a momentous year for community pharmacy in Canada. All provinces further expanded pharmacists’ scope of practice and/or increased
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. The date January 1 can have varying meanings for people. It’s the first day of a new year, of course.
